Richard Ian Griffiths - 18 May 2025 Form 4 Insider Report for Silence Therapeutics plc (SLN)

Role
10%+ Owner
Signature
/s/ Richard Ian Griffiths
Issuer symbol
SLN
Transactions as of
18 May 2025
Net transactions value
$0
Form type
4
Filing time
21 May 2025, 06:49:38 UTC
Previous filing
15 May 2025
Next filing
27 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Griffiths Richard Ian 10%+ Owner FLOOR 1 LIBERATION STATION, ESPLANADE, ST HELIER, JERSEY /s/ Richard Ian Griffiths 21 May 2025 0001846370

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLN American Depositary Shares Purchase +37,023 +0.33% 11,157,876 18 May 2025 Ordinary Shares 111,069 $4.01 Direct F1
transaction SLN American Depositary Shares Purchase +26,000 +0.23% 11,183,876 19 May 2025 Ordinary Shares 78,000 $4.07 Direct F1
transaction SLN American Depositary Shares Purchase +16,000 +0.14% 11,199,876 20 May 2025 Ordinary Shares 48,000 $4.07 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each American Depositary Share ("ADS") is immediately convertible into three ordinary shares for no consideration and has no expiration date.